Schuurman P R, Speelman J D, de Bie R M, Bosch D A
Academisch Medisch Centrum, afd. Neurologie en Neurochirurgie, Amsterdam.
Ned Tijdschr Geneeskd. 1998 Jan 3;142(1):10-4.
For patients with Parkinson's disease who have become unresponsive to pharmacotherapy or have developed severe motor complications due to medical therapy, a number of symptomatic neurosurgical interventions are available: thalamotomy, thalamic stimulation and pallidotomy. These stereotactic operations are performed under local anaesthesia. The target is located using anatomical and physiological techniques, after which the neuro-ablative or neuromodulatory procedure is performed. The choice of the target depends on the symptoms of the patient that most impair daily functioning. In case of dominating tremor, thalamic surgery is performed. Patients who are mainly incapacitated by rigidity, hypokinesia or pharmacotherapy-induced dyskinesias are suitable candidates for pallidotomy. Contraindications are cognitive dysfunction, severe disturbance of gait and balance, advanced cerebral atrophy on CT or MRI, limited life expectancy and a poor general condition enhancing surgical risk, e.g. coagulation disorders or uncontrolled hypertension. Surgical treatment of Parkinson's disease is being carried out in clinical trials in the Netherlands in the Academic Medical Centre in Amsterdam, the Academic Hospital in Groningen and the St. Elisabeth Hospital in Tilburg.
对于那些对药物治疗无反应或因药物治疗出现严重运动并发症的帕金森病患者,有多种对症神经外科干预措施可供选择:丘脑切开术、丘脑刺激术和苍白球切开术。这些立体定向手术在局部麻醉下进行。使用解剖学和生理学技术定位靶点,之后进行神经毁损或神经调节手术。靶点的选择取决于最影响日常功能的患者症状。如果震颤为主,则进行丘脑手术。主要因强直、运动迟缓或药物治疗引起的异动症而丧失能力的患者是苍白球切开术的合适人选。禁忌证包括认知功能障碍、严重步态和平衡障碍、CT或MRI显示的晚期脑萎缩、预期寿命有限以及一般状况差增加手术风险,如凝血障碍或未控制的高血压。荷兰的阿姆斯特丹学术医疗中心、格罗宁根学术医院和蒂尔堡圣伊丽莎白医院正在开展帕金森病手术治疗的临床试验。